Algernon Pharmaceuticalsinc (AGN.CN)
0.0800 x 23000 0.0950 x 105000
Post-market by (Cboe BZX)
0.0850 -0.0100 (-10.53%) 03/28/25 [CNSX]
0.0800 x 23000 0.0950 x 105000
Post-market 0.0850 unch (unch) 14:55 ET
for Fri, Mar 28th, 2025
Fiscal Year End Date: 08/31
08-2019 | 08-2018 | 08-2017 | 08-2016 | 08-2015 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 208 | 1,251 | 1,393 | 1,598 | 162 |
Receivables | 45 | 11 | 9 | 34 | N/A |
TOTAL | $279 | $1,295 | $1,470 | $1,711 | $209 |
Non-Current Assets | |||||
PPE Net | 0 | 54 | 68 | 28 | N/A |
Intangibles | 5,000 | 73 | 97 | 532 | N/A |
Other Non-Current Assets | 59 | 1 | 1 | 1 | 0 |
TOTAL | $5,059 | $128 | $167 | $562 | $0 |
Total Assets | $5,338 | $1,423 | $1,637 | $2,273 | $209 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 2 |
Accrued Expenses | N/A | N/A | N/A | N/A | 5 |
TOTAL | $365 | $57 | $48 | $150 | $7 |
Non-Current Liabilities | |||||
TOTAL | $0 | $0 | $0 | $0 | $0 |
Total Liabilities | $365 | $57 | $48 | $150 | $7 |
Shareholders' Equity | |||||
Common Shares | 12,587 | 8,569 | 7,990 | 0 | 0 |
Retained earnings | -10,269 | -8,929 | -8,824 | -7,303 | -54 |
Other shareholders' equity | 2,654 | 1,726 | 2,423 | 2,190 | 0 |
TOTAL | $4,973 | $1,366 | $1,589 | $2,123 | $202 |
Total Liabilities And Equity | $5,338 | $1,423 | $1,637 | $2,273 | $209 |